Polymer Capital Management US LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 23,842 shares of the pharmacy operator's stock, valued at approximately $222,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. First Financial Corp IN raised its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Riverview Trust Co raised its stake in shares of Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares during the period. Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $28,000. Finally, TD Private Client Wealth LLC boosted its position in shares of Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after buying an additional 3,208 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on WBA. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Friday. They issued a "hold" rating for the company. Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Finally, Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of "Hold" and a consensus price target of $10.59.
Get Our Latest Analysis on WBA
Walgreens Boots Alliance Stock Up 1.5 %
Shares of Walgreens Boots Alliance stock traded up $0.16 during trading hours on Monday, hitting $10.94. The company had a trading volume of 2,772,816 shares, compared to its average volume of 20,955,468. The company's 50-day moving average is $10.75 and its two-hundred day moving average is $10.08. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.83. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company has a market cap of $9.45 billion, a P/E ratio of -1.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.20 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.